Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06165952 · ClinicalTrials.gov registry record
Effects of Processed Foods on Brain Reward Circuitry and Food Cue Learning
A clinical trial of Ultra-processed Foods (UP), sponsored by Stanford University.
- Recruiting
- Registry status
- 162
- Enrollment target
- 1
- Study location
NCT06165952: Recruiting study of Ultra-processed Foods (UP), sponsored by Stanford University.
NCT06165952 is a study of Ultra-processed Foods (UP) that is actively recruiting participants, run by Stanford University. The registered enrollment target is 162 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06165952, a study of Ultra-processed Foods (UP), is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
Examine if ultra-processed (UP) foods are more effective in activating reward, attention, and memory brain regions and in promoting food cue learning than minimally-processed foods. Assess individual differences in neurobehavioral responses to UP foods.
Primary Outcome
Investigators will use air displacement plethysmography (ADP) via the Bod Pod and bioelectrical impedance (BIA) via the SECA medical body composition analyzer (SECA mBCA) to assess % body fat. The investigators will average the values of both measures. Body density is calculated as body mass divided by body volume; body density is used to calculate % body fat. ADP % body fat shows high test-retest reliability (r = .92-.99) and correlates with dual energy x-ray absorptiometry (DEXA) and hydrostat
Conditions Studied
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2024-10-04 |
| Est. Completion | 2029-02-28 |
What NCT06165952 shows while recruiting
NCT06165952 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Ultra-processed Foods (UP) appearing as the primary indexed condition, and to 0 interventions.
NCT06165952 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06165952 about?
NCT06165952 is a clinical study titled "Effects of Processed Foods on Brain Reward Circuitry and Food Cue Learning". Examine if ultra-processed (UP) foods are more effective in activating reward, attention, and memory brain regions and in promoting food cue learning than minimally-processed foods. Assess individual differences in neurobehavioral responses to UP foods.
What is the current status of trial NCT06165952?
This trial is currently recruiting. The enrollment target is 162 participants. The study started on 2024-10-04. Estimated completion is 2029-02-28.
What conditions does trial NCT06165952 study?
This clinical trial studies the following conditions: Ultra-processed Foods (UP).
Who is sponsoring clinical trial NCT06165952?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06165952 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI